| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 128,187 | 122,026 | 116,310 | 135,301 | | Cost of Revenue | 23,889 | 24,058 | 23,628 | 25,390 | | | Gross Profit | 104,298 | 97,968 | 92,682 | 109,911 | | | Operating Expenses | | Research Development | 19,462 | 19,909 | 20,030 | 18,826 | | Selling General and Administrative | 31,719 | 32,570 | 33,825 | 41,954 | | Non Recurring | 1,370 | 808 |
-
|
-
| | Others | 4,115 | 4,021 | 3,998 | 3,351 | | | | Total Operating Expenses | 56,666 | 57,308 |
-
|
-
| | | | Operating Income or Loss | 47,632 | 40,660 | 34,829 | 45,780 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 479 | (457) | 81 | 1,541 | | Earnings Before Interest And Taxes | 48,111 | 40,203 | 34,910 | 47,321 | | Interest Expense | 2,313 | 2,941 | 3,277 | 3,993 | | Income Before Tax | 45,798 | 37,262 | 31,633 | 43,328 | | Income Tax Expense | 15,269 | 10,125 | 10,538 | 11,415 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,529 | 27,137 | 21,095 | 31,913 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,529 | 27,137 | 21,095 | 31,913 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,529 | $27,137 | $21,095 | $31,913 |
|
1.52% Nasdaq 
Income Statement
